Research and development costs

12 Months Ended

Dec. 31, 2024

Research and development costs [Abstract]

Research and development costs

5. Research and development costs

	2024		2023		2022
		A$’000		A$’000	A$’000
Therapeutics
TLX591 (Phase 3)		44,879		23,975		15,518
TLX250, TLX101 (Phase 2)		12,404		10,441		8,241
TLX66, TLX300 (Phase 1)		10,900		4,534		1,605
Pre-clinical research and innovation		14,399		8,616		7,038
Total Therapeutics R&D		82,582		47,566		32,402
Precision Medicine
Illuccix, TLX591-CDx (Commercial)		14,725		10,565		10,611
Pixclara, Zircaix, Gozellix (Pre-commercial)		88,754		59,605		31,667
Pre-clinical research and innovation		7,869		10,157		6,007
Total Precision Medicine R&D		111,348		80,327		48,285
Total product development R&D		193,930		127,893		80,687
Manufacturing Solutions
Other research and development projects		707		644		-
Total Manufacturing Solutions R&D		707		644		-
Total research and development costs		194,637		128,537		80,687

Other research and development projects includes research and innovation costs and other early-stage development projects.